Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 102

1.

Isolated Posterior Spinal Artery Aneurysm Presenting With Spontaneous Thrombosis After Subarachnoid Hemorrhage: A Case Report.

Takebayashi K, Ishikawa T, Murakami M, Funatsu T, Ishikawa T, Taira T, Kawamata T.

World Neurosurg. 2019 Nov 28. pii: S1878-8750(19)32958-4. doi: 10.1016/j.wneu.2019.11.118. [Epub ahead of print]

PMID:
31786383
2.

Impact of Late Ventricular Arrhythmias on Cardiac Mortality in Patients with Acute Myocardial Infarction.

Takada T, Shishido K, Hayashi T, Yokota S, Miyashita H, Yokoyama H, Nishimoto T, Ochiai T, Moriyama N, Tobita K, Mizuno S, Yamanaka F, Murakami M, Tanaka Y, Takahashi S, Saito S.

J Interv Cardiol. 2019 Jul 8;2019:5345178. doi: 10.1155/2019/5345178. eCollection 2019.

3.

Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan - Findings From the AF Frontier Ablation Registry.

Okumura Y, Nagashima K, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Kato T, Shimizu W, Iwasaki YK, Hayashi H, Harada T, Nakajima I, Okumura K, Koyama J, Tokuda M, Yamane T, Momiyama Y, Tanimoto K, Soejima K, Nonoguchi N, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Satomi K, Yazaki Y, Watari Y; AF Ablation Frontier Registry.

Circ J. 2019 Nov 25;83(12):2418-2427. doi: 10.1253/circj.CJ-19-0602. Epub 2019 Oct 16.

4.

A conditional inducible JAK2V617F transgenic mouse model reveals myeloproliferative disease that is reversible upon switching off transgene expression.

Chapeau EA, Mandon E, Gill J, Romanet V, Ebel N, Powajbo V, Andraos-Rey R, Qian Z, Kininis M, Zumstein-Mecker S, Ito M, Hynes NE, Tiedt R, Hofmann F, Eshkind L, Bockamp E, Kinzel B, Mueller M, Murakami M, Baffert F, Radimerski T.

PLoS One. 2019 Oct 10;14(10):e0221635. doi: 10.1371/journal.pone.0221635. eCollection 2019.

5.

Efficacy and safety of quizartinib in Japanese patients with FLT3-ITD positive relapsed or refractory acute myeloid leukemia in an open-label, phase 2 study.

Takahashi T, Usuki K, Matsue K, Ohno H, Sakura T, Imanaka R, Murakami M, Ohwada S, Takagi T, Sakajiri S.

Int J Hematol. 2019 Dec;110(6):665-674. doi: 10.1007/s12185-019-02727-6. Epub 2019 Aug 31.

PMID:
31473943
6.

A Novel HER3-Targeting Antibody-Drug Conjugate, U3-1402, Exhibits Potent Therapeutic Efficacy through the Delivery of Cytotoxic Payload by Efficient Internalization.

Hashimoto Y, Koyama K, Kamai Y, Hirotani K, Ogitani Y, Zembutsu A, Abe M, Kaneda Y, Maeda N, Shiose Y, Iguchi T, Ishizaka T, Karibe T, Hayakawa I, Morita K, Nakada T, Nomura T, Wakita K, Kagari T, Abe Y, Murakami M, Ueno S, Agatsuma T.

Clin Cancer Res. 2019 Dec 1;25(23):7151-7161. doi: 10.1158/1078-0432.CCR-19-1745. Epub 2019 Aug 30.

PMID:
31471314
7.

FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer.

Weiss A, Adler F, Buhles A, Stamm C, Fairhurst RA, Kiffe M, Sterker D, Centeleghe M, Wartmann M, Kinyamu-Akunda J, Schadt HS, Couttet P, Wolf A, Wang Y, Barzaghi-Rinaudo P, Murakami M, Kauffmann A, Knoepfel T, Buschmann N, Leblanc C, Mah R, Furet P, Blank J, Hofmann F, Sellers WR, Graus Porta D.

Mol Cancer Ther. 2019 Dec;18(12):2194-2206. doi: 10.1158/1535-7163.MCT-18-1291. Epub 2019 Aug 13.

PMID:
31409633
8.

Microstructure and Flux Pinning of Reacted-and-Pressed, Polycrystalline Ba0.6K0.4Fe2As2 Powders.

Koblischka MR, Koblischka-Veneva A, Schmauch J, Murakami M.

Materials (Basel). 2019 Jul 6;12(13). pii: E2173. doi: 10.3390/ma12132173.

9.

Anomalous origin of the coronary artery coursing between the great vessels presenting with a cardiovascular event (J-CONOMALY Registry).

Nagashima K, Hiro T, Fukamachi D, Okumura Y, Watanabe I, Hirayama A, Tanaka M, Tanaka T, Takamisawa I, Taguchi I, Sato A, Aonuma K, Fukamizu S, Nakada A, Watanabe A, Amioka N, Suzuki Y, Matsumoto N, Koizumi J, Kumagai K, Naya M, Higuchi Y, Naito Y, Masuyama T, Kawamura M, Tsunoda R, Suzuki S, Ishii H, Murohara T, Shimizu T, Takeishi Y, Shiina K, Yamashita J, Imamura T, Sumitomo N, Noguchi T, Aso T, Furukawa K, Yamauchi Y, Okishige K, Sakata K, Yamagishi M, Shimizu S, Ohno M, Sugano T, Matsumura K, Matsumoto K, Ozaki K, Hayashidani S, Meno H, Iwata A, Higuma T, Tomita H, Yoshino H, Taniai S, Shishido K, Murakami M, Negishi K, Nii M, Wakatsuki D, Suzuki H, Motoike Y, Ozaki Y, Nakazato J, Hayashi H, Higuchi S, Shoda M.

Eur Heart J Cardiovasc Imaging. 2019 Apr 25. pii: jez076. doi: 10.1093/ehjci/jez076. [Epub ahead of print]

PMID:
31185091
10.

Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillation.

Okishige K, Yamauchi Y, Hanaki Y, Inoue K, Tanaka N, Yamaji H, Murakami T, Manita M, Tabata K, Ooie T, Tatsukawa Y, Sakai H, Yamaki M, Murakami M, Takada T, Osaka Y, Ono Y, Handa K, Sugiyama K, Yoshizawa T, Fukaya H, Tashiro H, Takase S, Harada M, Watanabe E, Yamane T, Yamashita S, Aonuma K.

J Thromb Thrombolysis. 2019 May;47(4):487-494. doi: 10.1007/s11239-019-01835-8.

PMID:
30955142
11.

Superconducting YBCO Foams as Trapped Field Magnets.

Koblischka MR, Naik SPK, Koblischka-Veneva A, Murakami M, Gokhfeld D, Reddy ES, Schmitz GJ.

Materials (Basel). 2019 Mar 13;12(6). pii: E853. doi: 10.3390/ma12060853.

12.

Instantaneous Wave-Free Ratio for the Assessment of Intermediate Coronary Artery Stenosis in Patients With Severe Aortic Valve Stenosis: Comparison With Myocardial Perfusion Scintigraphy.

Yamanaka F, Shishido K, Ochiai T, Moriyama N, Yamazaki K, Sugitani A, Tani T, Tobita K, Mizuno S, Tanaka Y, Murakami M, Takahashi S, Yamazaki S, Saito S.

JACC Cardiovasc Interv. 2018 Oct 22;11(20):2032-2040. doi: 10.1016/j.jcin.2018.07.027. Epub 2018 Aug 25.

13.

Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53-MDM2 Inhibitor HDM201.

Jeay S, Ferretti S, Holzer P, Fuchs J, Chapeau EA, Wartmann M, Sterker D, Romanet V, Murakami M, Kerr G, Durand EY, Gaulis S, Cortes-Cros M, Ruetz S, Stachyra TM, Kallen J, Furet P, Würthner J, Guerreiro N, Halilovic E, Jullion A, Kauffmann A, Kuriakose E, Wiesmann M, Jensen MR, Hofmann F, Sellers WR.

Cancer Res. 2018 Nov 1;78(21):6257-6267. doi: 10.1158/0008-5472.CAN-18-0338. Epub 2018 Aug 22.

14.

Neoatherosclerosis 5 Years After Bioresorbable Vascular Scaffold Implantation.

Moriyama N, Shishido K, Tanaka Y, Yokota S, Hayashi T, Miyashita H, Koike T, Yokoyama H, Takada T, Nishimoto T, Ochiai T, Tobita K, Yamanaka F, Mizuno S, Murakami M, Takahashi S, Saito S.

J Am Coll Cardiol. 2018 May 1;71(17):1882-1893. doi: 10.1016/j.jacc.2018.02.051.

PMID:
29699614
15.

Comparison of uninterrupted anticoagulation with dabigatran etexilate or warfarin in the periprocedural period for atrial fibrillation catheter ablation: Results of the Japanese subgroup of the RE-CIRCUIT trial.

Yoshida Y, Watarai M, Fujii K, Shimizu W, Satomi K, Inden Y, Murakami Y, Murakami M, Iwasa A, Kimura M, Yamada N, Nakagawa T, Nordaby M, Okumura K.

J Arrhythm. 2018 Jan 13;34(2):148-157. doi: 10.1002/joa3.12024. eCollection 2018 Apr.

16.

The COFFEE Trial (COmparison of Fractional Flow Reserve Measurements through 4 FrEnch versus 6 FrEnch Diagnostic Catheter).

Moriyama N, Yamanaka F, Shishido K, Tobita K, Yokota S, Hayashi T, Koike T, Miyashita H, Yokoyama H, Nishimoto T, Takada T, Ochiai T, Mizuno S, Tanaka Y, Murakami M, Takahashi S, Saito S.

JACC Cardiovasc Interv. 2018 Feb 26;11(4):414-416. doi: 10.1016/j.jcin.2017.12.007. No abstract available.

17.

Modified jailed balloon technique for bifurcation lesions.

Saito S, Shishido K, Moriyama N, Ochiai T, Mizuno S, Yamanaka F, Sugitatsu K, Tobita K, Matsumi J, Tanaka Y, Murakami M.

Catheter Cardiovasc Interv. 2018 Sep 1;92(3):E218-E226. doi: 10.1002/ccd.27334. Epub 2017 Dec 4.

PMID:
29205789
18.

Impact of premature activation of the right ventricle with programmed stimulation in Brugada syndrome.

Nakagawa K, Nagase S, Morita H, Wada T, Tanaka M, Murakami M, Watanabe A, Nishii N, Nakamura K, Kusano KF, Ito H, Ohe T.

J Cardiovasc Electrophysiol. 2018 Jan;29(1):71-78. doi: 10.1111/jce.13336. Epub 2017 Sep 26.

PMID:
28884873
19.

Reply: Slender Sheaths Have the Potential to Expand the Use of Transradial Access for Complex CTO-PCI.

Tanaka Y, Moriyama N, Ochiai T, Takada T, Tobita K, Shishido K, Sugitatsu K, Yamanaka F, Mizuno S, Murakami M, Matsumi J, Takahashi S, Akasaka T, Saito S.

JACC Cardiovasc Interv. 2017 May 22;10(10):1071. doi: 10.1016/j.jcin.2017.03.017. No abstract available.

20.

Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.

Calkins H, Willems S, Gerstenfeld EP, Verma A, Schilling R, Hohnloser SH, Okumura K, Serota H, Nordaby M, Guiver K, Biss B, Brouwer MA, Grimaldi M; RE-CIRCUIT Investigators.

N Engl J Med. 2017 Apr 27;376(17):1627-1636. doi: 10.1056/NEJMoa1701005. Epub 2017 Mar 19.

Supplemental Content

Loading ...
Support Center